Hypersensitivity reactions to intravenous antibiotics are common in cystic fibrosis (CF). As well as causing immediate morbidity, the need for future avoidance of the causative antibiotic can have a long-term negative impact on CF management. This paper reviews the epidemiology and clinical presentation of hypersensitivity reactions in CF patients, and using an illustrative case describes a rare but severe form of delayed drug reaction for which a high index of suspicion is required.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.prrv.2018.01.003 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!